Search Within

Smita Sarat Chandran

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Adult Leukemia (4)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  3. Breast Medicine Service (4)
  4. Center for Hematologic Malignancies (4)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  6. Department of Medicine (4)

More Groups

People
  1. Christopher Klebanoff (4)
  2. David Scheinberg (4)
  3. Martin Klatt (4)
  4. Matthew Femia (2)
  5. Aaron Chang (1)
  6. Alexander Drilon (1)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (2)
Publications
  1. Cancer Immunology Research (1)
  2. Journal for ImmunoTherapy of Cancer (1)
  3. Molecular Cancer Therapeutics (1)
  4. Nature Medicine (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Biomed Central Ltd (1)
  3. Nature Publishing Group (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
    Journal Article

    Chandran, S. S.; Ma, J.; Klatt, M. G.; Dündar, F.; Bandlamudi, C.; Razavi, P.; Wen, H. Y.; Weigelt, B.; Zumbo, P.; Fu, S. N.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform
    Journal Article

    Gejman, R. S.; Jones, H. F.; Klatt, M. G.; Chang, A. Y.; Oh, C. Y.; Chandran, S. S.; Korontsvit, T.; Zakahleva, V.; Dao, T.; Klebanoff, C. A.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save